Replies to post #227545 on Avid Bioservices Inc (CDMO)

[MazelMan]

Thanks CP.

Hoping for the best.

D

[pphmtoolong]

CP, my research on DMC's suggests the data released at these interim reports is governed by written instructions from Peregrine. The only instruction in this regard by the FDA is the data released should not compromise the double-blind nature of the trial.

My question to Peregrine IR, so far unanswered, was what kind of information could be released as part of an interim report. I suppose it could vary quite a bit. From gross enrollment data to enrollment data by region to who knows what.

I don't see what harm could be done by Peregrine sharing something regarding these DMC guidelines.

GLTA, Especially Bavi-arm Sunrise Patients,

Paul